Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
NCT: NCT07766161 · RECRUITING
Brief Summary
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Frequently Asked Questions
What is Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression?
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression is a clinical trial registered under NCT07766161. Current status: RECRUITING.
What is the status of NCT07766161?
The current status of NCT07766161 (Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression) is: RECRUITING.
When did Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression start?
Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression started on 2026-07-29.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.